Abstract: Papillary (PTC) and follicular (FTC) thyroid carcinomas require different treatment strategies, but their accurate differentiation remains a challenge in conventional histopathology.

These findings suggest that TrpC5 may serve as a potential therapeutic target for PTC and warrant further investigation in vivo. In this study, we demonstrated that TrpC5 expression was upregulated in ...

Long-Term Survivorship After Chimeric Antigen Receptor T-Cell Therapy for Hematologic Malignancies This phase I/II, open-label, multicenter study evaluated pivekimab sunirine (PVEK), a novel CD123 ...

Bilaterality serves as an independent predictor of recurrence-free survival in patients with papillary thyroid carcinoma, correlating with significantly shorter survival compared with unilateral ...